Photodynamic therapy for squamous cell oral and lower lip carcinoma

Treatment outcomes in 82 patients with primary and recurrent oral and lower lip cancer after photodynamic therapy with photosensitizer Photolon alone or combined with other methods of cancer treatment are represented. According to type and extent of the tumor the single dose of Photolon for intraven...

Full description

Saved in:
Bibliographic Details
Main Authors: V. V. Poljkin, I. S. Spichenkova, М. А. Kaplan, V. S. Medvedev, V. N. Kapinus, Е. V. Yaroslavtseva-Isaeva, А. М. Shubina, Е. V. Goranskaya, D. Yu. Syomin, М. U. Radjapova
Format: Article
Language:Russian
Published: Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association" 2013-03-01
Series:Biomedical Photonics
Subjects:
Online Access:https://www.pdt-journal.com/jour/article/view/2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849689617359437824
author V. V. Poljkin
I. S. Spichenkova
М. А. Kaplan
V. S. Medvedev
V. N. Kapinus
Е. V. Yaroslavtseva-Isaeva
А. М. Shubina
Е. V. Goranskaya
D. Yu. Syomin
М. U. Radjapova
author_facet V. V. Poljkin
I. S. Spichenkova
М. А. Kaplan
V. S. Medvedev
V. N. Kapinus
Е. V. Yaroslavtseva-Isaeva
А. М. Shubina
Е. V. Goranskaya
D. Yu. Syomin
М. U. Radjapova
author_sort V. V. Poljkin
collection DOAJ
description Treatment outcomes in 82 patients with primary and recurrent oral and lower lip cancer after photodynamic therapy with photosensitizer Photolon alone or combined with other methods of cancer treatment are represented. According to type and extent of the tumor the single dose of Photolon for intravenous administration accounted for 0.8–2.5 mg/kg, light dose – 100–400 J/cm2 (with wave length of 661 nm). 57 patients had PDT alone; 5 patients – in combination with distant radotherapy; 11 – with distant radiotherapy and polychemotherapy; 9 – with 252Cf interstitial therapy and polychemotherapy. For these patients 3-year overall survival rates were 85.1±4.8%, 3-year reccurence-free survival – 72.2±4.7%. The PDT for recurrent tumors, in cases when other methods were exhausted or impossible, allowed complete tumor response in 82.9% of patients, in 72.9% of them – 3-year disease free survivance. For PDT combined with distant radiotherapy (including concurrent polychemotherapy) the complete response was observed in 100% of patients with primary tumor and in 66.7% of patients with recurrent tumor. For PDT combined with interstitial neutron therapy all patients had complete tumor response. The study showed that this combination allowed decreasing the total radiation dose and radiation dose on adjacent normal tissue, thus, decreasing radiation injury.
format Article
id doaj-art-754cc42df18a4ae4809d6370e57eede5
institution DOAJ
issn 2413-9432
language Russian
publishDate 2013-03-01
publisher Non-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"
record_format Article
series Biomedical Photonics
spelling doaj-art-754cc42df18a4ae4809d6370e57eede52025-08-20T03:21:34ZrusNon-profit partnership for development of domestic photodynamic therapy and photodiagnosis "Russian Photodynamic Association"Biomedical Photonics2413-94322013-03-012111192Photodynamic therapy for squamous cell oral and lower lip carcinomaV. V. Poljkin0I. S. Spichenkova1М. А. Kaplan2V. S. Medvedev3V. N. Kapinus4Е. V. Yaroslavtseva-Isaeva5А. М. Shubina6Е. V. Goranskaya7D. Yu. Syomin8М. U. Radjapova9Medical Radiological Research Centre, Obninsk, RussiaMedical Radiological Research Centre, Obninsk, RussiaMedical Radiological Research Centre, Obninsk, RussiaMedical Radiological Research Centre, Obninsk, RussiaMedical Radiological Research Centre, Obninsk, RussiaMedical Radiological Research Centre, Obninsk, RussiaMedical Radiological Research Centre, Obninsk, RussiaMedical Radiological Research Centre, Obninsk, RussiaMedical Radiological Research Centre, Obninsk, RussiaMedical Radiological Research Centre, Obninsk, RussiaTreatment outcomes in 82 patients with primary and recurrent oral and lower lip cancer after photodynamic therapy with photosensitizer Photolon alone or combined with other methods of cancer treatment are represented. According to type and extent of the tumor the single dose of Photolon for intravenous administration accounted for 0.8–2.5 mg/kg, light dose – 100–400 J/cm2 (with wave length of 661 nm). 57 patients had PDT alone; 5 patients – in combination with distant radotherapy; 11 – with distant radiotherapy and polychemotherapy; 9 – with 252Cf interstitial therapy and polychemotherapy. For these patients 3-year overall survival rates were 85.1±4.8%, 3-year reccurence-free survival – 72.2±4.7%. The PDT for recurrent tumors, in cases when other methods were exhausted or impossible, allowed complete tumor response in 82.9% of patients, in 72.9% of them – 3-year disease free survivance. For PDT combined with distant radiotherapy (including concurrent polychemotherapy) the complete response was observed in 100% of patients with primary tumor and in 66.7% of patients with recurrent tumor. For PDT combined with interstitial neutron therapy all patients had complete tumor response. The study showed that this combination allowed decreasing the total radiation dose and radiation dose on adjacent normal tissue, thus, decreasing radiation injury.https://www.pdt-journal.com/jour/article/view/2photodynamic therapycombined modality treatmentcancer of lower liporal cancerphotosensitizer photolon
spellingShingle V. V. Poljkin
I. S. Spichenkova
М. А. Kaplan
V. S. Medvedev
V. N. Kapinus
Е. V. Yaroslavtseva-Isaeva
А. М. Shubina
Е. V. Goranskaya
D. Yu. Syomin
М. U. Radjapova
Photodynamic therapy for squamous cell oral and lower lip carcinoma
Biomedical Photonics
photodynamic therapy
combined modality treatment
cancer of lower lip
oral cancer
photosensitizer photolon
title Photodynamic therapy for squamous cell oral and lower lip carcinoma
title_full Photodynamic therapy for squamous cell oral and lower lip carcinoma
title_fullStr Photodynamic therapy for squamous cell oral and lower lip carcinoma
title_full_unstemmed Photodynamic therapy for squamous cell oral and lower lip carcinoma
title_short Photodynamic therapy for squamous cell oral and lower lip carcinoma
title_sort photodynamic therapy for squamous cell oral and lower lip carcinoma
topic photodynamic therapy
combined modality treatment
cancer of lower lip
oral cancer
photosensitizer photolon
url https://www.pdt-journal.com/jour/article/view/2
work_keys_str_mv AT vvpoljkin photodynamictherapyforsquamouscelloralandlowerlipcarcinoma
AT isspichenkova photodynamictherapyforsquamouscelloralandlowerlipcarcinoma
AT makaplan photodynamictherapyforsquamouscelloralandlowerlipcarcinoma
AT vsmedvedev photodynamictherapyforsquamouscelloralandlowerlipcarcinoma
AT vnkapinus photodynamictherapyforsquamouscelloralandlowerlipcarcinoma
AT evyaroslavtsevaisaeva photodynamictherapyforsquamouscelloralandlowerlipcarcinoma
AT amshubina photodynamictherapyforsquamouscelloralandlowerlipcarcinoma
AT evgoranskaya photodynamictherapyforsquamouscelloralandlowerlipcarcinoma
AT dyusyomin photodynamictherapyforsquamouscelloralandlowerlipcarcinoma
AT muradjapova photodynamictherapyforsquamouscelloralandlowerlipcarcinoma